The creation of disease-specific stem cells will advance research into degenerative disorders and allow scientists to examine how environmental factors influence illnesses, said Doug Melton, co-director of the Harvard Stem Cell Institute. The institute intends to distribute the cell lines to other scientists worldwide to encourage "basic research" on embryonic stem cells, Melton said.

Related Summaries